Abstract
Transcatheter aortic valve implantation (TAVI) has becomein recent years a safe and efficient treatment formost patients with symptomatic severe aortic stenosis,regardless of the risk group to which they belong. Thetransfemoral access (TF) has been largely responsiblefor this success and has become the “gold standard”, inaddition to being the most frequently used.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
